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MaOBJECTIVES The purpose of this study was to evaluate whether radiation exposure from cardiac computed tomo-
graphic angiography (CTA) is associated with deoxyribonucleic acid (DNA) damage and whether damage leads to pro-
grammed cell death and activation of genes involved in apoptosis and DNA repair.
BACKGROUND Exposure to radiation from medical imaging has become a public health concern, but whether it causes
signiﬁcant cell damage remains unclear.
METHODS We conducted a prospective cohort study in 67 patients undergoing cardiac CTA between January 2012 and
December 2013 in 2 U.S. medical centers. Median blood radiation exposure was estimated using phantom dosimetry.
Biomarkers of DNA damage and apoptosis were measured by ﬂow cytometry, whole genome sequencing, and single cell
polymerase chain reaction.
RESULTS The median dose length product was 1,535.3 mGy$cm (969.7 to 2,674.0 mGy$cm). The median radiation dose
to the blood was 29.8 mSv (18.8 to 48.8 mSv). Median DNA damage increased 3.39% (1.29% to 8.04%, p < 0.0001) and
median apoptosis increased 3.1-fold (interquartile range [IQR]: 1.4- to 5.1-fold, p < 0.0001) post-radiation. Whole
genome sequencing revealed changes in the expression of 39 transcription factors involved in the regulation of
apoptosis, cell cycle, and DNA repair. Genes involved in mediating apoptosis and DNA repair were signiﬁcantly changed
post-radiation, including DDB2 (1.9-fold [IQR: 1.5- to 3.0-fold], p < 0.001), XRCC4 (3.0-fold [IQR: 1.1- to 5.4-fold],
p ¼ 0.005), and BAX (1.6-fold [IQR: 0.9- to 2.6-fold], p < 0.001). Exposure to radiation was associated with DNA
damage (odds ratio [OR]: 1.8 [1.2 to 2.6], p ¼ 0.003). DNA damage was associated with apoptosis (OR: 1.9 [1.2 to 5.1],
p < 0.0001) and gene activation (OR: 2.8 [1.2 to 6.2], p ¼ 0.002).
CONCLUSIONS Patients exposed to >7.5 mSv of radiation from cardiac CTA had evidence of DNA damage, which
was associated with programmed cell death and activation of genes involved in apoptosis and DNA repair.
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ABBR EV I A T I ON S
AND ACRONYMS
BAX = BCL2-associated X
protein
CTA = computed tomographic
angiography
DDB2 = damage-speciﬁc
deoxyribonucleic acid binding
protein 2
H2AX = H2A histone family,
member X
XRCC4 = x-ray repair
complementing defective
repair in Chinese hamster
cells 4
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874T he application of cardiac computedtomographic angiography (CTA) hasrisen dramatically over the last
decade (1–3). Cardiac CTA is now commonly
used to manage patients with suspected cor-
onary artery disease (4), aortic stenosis in
preparation for transcatheter aortic valve
replacement (5), atrial ﬁbrillation prior to
ablation (6), and aortic dissection post-
surgical repair (7). Radiation exposure from
this procedure can be signiﬁcant because of
the need for gating to compensate for cardiac
motion. A single cardiac CTA can expose pa-
tients to a radiation dose equivalent to hav-ing at $150 chest x-rays (8). Not surprisingly, the
widespread use of this procedure has raised concern
among physicians and patients about the potential
deleterious effects of radiation exposure from cardiac
CTA (9).SEE PAGE 885It is well known that exposure of cells to therapeutic
doses of radiation triggers a complex network of signal
transduction pathways that induce changes in gene
expression and protein structure (10). This results
in apoptosis (e.g., programmed cell death), cell cycle
arrest or progression, and deoxyribonucleic acid
(DNA) repair to minimize the risk of mutagenesis (11).
Whether radiation doses from medical imaging tests
(<100 mSv) causes similar damage and activates the
same biological pathways is less certain. Although
previous studies have demonstrated that proteins
involved in the DNA damage response pathway are
phosphorylated after exposure to radiation from
medical imaging (12–14), these clinical studies have
been limited by the use of semiqualitative measures,
speciﬁcally counting the formation of gamma H2A
histone family, member X (H2AX) foci in a small subset
of cells (12–14). Furthermore, prior studies have not
measured the effects of radiation exposure from
medical imaging on other key signaling proteins in the
DNA damage response pathways, which are also
altered after exposure to therapeutic doses of radiation
(15), nor have they determined whether radiation
from medical imaging is associated with programmed
cell death. Finally, no human studies to date have
measured the effects of radiation exposure from
medical imaging on changes in gene expression in vivo
(16), which have been shown to be signiﬁcantly
up-regulated after radiation therapy (17–19).
The purpose of our prospective study is to deter-
mine whether radiation exposure from cardiac CTA
is associated with DNA damage and whether the
extent of damage is associated with the activation ofpathways responsible for repairing or eliminating cells
to minimize mutation risk. The results of this study
will help clinicians better understand the risks asso-
ciated with radiation exposure from medical imaging
so that clinicians and patients can make informed de-
cisions about this procedure. This study will also help
determine whether additional strategies are needed to
protect patients against radiation exposure from CTA.
METHODS
Please refer to the Online Appendix for a more
detailed description of the methods.
PATIENTS AND DIAGNOSTIC IMAGING STUDIES. Adult
patients age $18 years who underwent a clinically
indicated cardiac CTA were recruited from Stanford
Hospital (Stanford, California) and the Veterans
Affairs Palo Alto Health Care System (Palo Alto,
California). This study complies with the institu-
tional review boards of Stanford University and
the Veterans Affairs Health Care System Palo Alto.
All subjects gave informed consent.
ESTIMATION OF RADIATION DOSE. Radiation dose
to the body and blood was estimated using phantom
dosimetery, the ImPACT Computed Tomography Pa-
tient Dosimetry Calculator spreadsheet (ImPACT,
London, England) (13,20). Only doses calculated from
the ImPACT Computed Tomography Patient Dosim-
etry Calculator were used in the analysis.
SAMPLE COLLECTION FOR IN VIVO STUDIES. Whole
blood was collected at baseline and at multiple time
points after cardiac CTA, as detailed in the Online
Appendix.
PROTEOMIC BIOMARKER ASSAYS. Analyses of pro-
tein biomarkers of DNA damage and apoptosis by ﬂow
cytometry and immunohistochemistry were per-
formed using standard protocols. DNA damage bio-
markers included phosphorylated H2AX, ataxia
telangiectasia mutated (ATM), and tumor protein
p53 (p53). Ten thousand cells were evaluated. Bio-
markers of apoptosis, including annexin V and BCL2-
associated X protein (BAX), were measured by ﬂow
cytometry and immunohistochemistry, respectively.
A total of 100,000 cells and 100 cells were evaluated
for the expression of apoptotic markers by ﬂow
cytometry and immunohistochemistry, respectively.
GENOMIC BIOMARKER ASSAYS. Whole genome
proﬁling using ribonucleic acid sequencing (n ¼ 3)
and single cell polymerase chain reaction (n ¼ 51) of
selected genes (Online Table 1) were performed using
standard protocols.
STATISTICAL ANALYSIS. Continuous variables with
normal distribution were expressed as mean  SD
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875and those thatwere not normally distributed asmedian
(ﬁrst quartile to third quartile), respectively. Observa-
tions from dichotomous variables were summarized as
proportions. Differences in continuous variables that
were normally distributed, continuous variables that
were not normally distributed, and proportions were
compared using the Student t, Wilcoxon sign ranked,
and Fisher exact tests respectively. Spearman correla-
tions (rho, 95% conﬁdence intervals, p value) were
used to assess associations between continuous vari-
ables. Analysis of whole genome sequencing data is
detailed in the Online Methods. Multivariate logistic
regression models were used to evaluate the asso-
ciation between blood radiation dose and the following
3 outcomes: 1) DNA damage; 2) programmed cell death;
and 3) gene activation. In addition to blood radiation
dose, the following 7 covariates were evaluated for the
presence of a signiﬁcant association or correlation to
the 3 outcomes identiﬁed above: 1) age; 2) sex; 3) body
mass index; 4) race; 5) history of smoking; 6) history of
cancer; and 7) iodine content. Only those covariates
with signiﬁcant associations with the 3 outcomes were
included in the model. Signiﬁcant DNA damage was
deﬁned as having $2% increase in phosphorylation of
at least one DNAmarker. A 2% cutoff was chosen based
on ﬁndings in patients undergoing echocardiography
(n ¼ 9), an imaging study that does not produce radi-
ation (data not shown). Patients who underwent
echocardiography had<1% change in phosphorylation;
thus, this cutoff is well above the level detected in our
negative control group. Statistical analysis was per-
formed using Intercooled Stata, version 12.1 (Stata
Corp, College Station, Texas). Tests had an alpha level
for signiﬁcance set at p < 0.05 for single comparisons.
The Bonferroni method was used to adjust the p values
for multiple testing. Unadjusted p values are shown,
and an asterisk is noted when comparisons were
signiﬁcant.
RESULTS
CLINICAL AND SCAN PARAMETERS. Of the 82 pa-
tients who were eligible to participate in the study,
67 patients underwent biomarker analysis before and
after exposure to cardiac CTA (Figure 1), using stan-
dard scanning protocols detailed in Online Table 2
and in the Online Appendix. Clinical and scan pa-
rameters are detailed in Table 1.
EXTENT OF DNA DAMAGE AND ITS ASSOCIATION
WITH CLINICAL AND SCAN PARAMETERS. A total
of 70% of patients (36 of 57) had $2% increase in
phosphorylation of at least 1 DNA damage marker post-
radiation exposure (Figures 2A and 2B), indicating that
at least 200 of 10,000 cells/patient had evidence ofDNA damage after cardiac CTA. The median change in
phosphorylation of any DNA damagemarker was 3.39%
(1.29% to 8.04%; *p < 0.0001). Although H2AX is more
commonly used to estimate the extent of DNA damage
(12–14,21), the median change in phosphorylation was
higher for ATM (1.7% [0.7% to 8.0%]; *p < 0.0001) than
both H2AX (0.2% [0% to 0.7%]; *p < 0.0001) and
p53 (0.5% [0.2% to 2.2%]; *p < 0.0001). This suggests
that phosphorylated ATM may be a more sensitive
biomarker for DNA damage. Median change in phos-
phorylation of any DNA damage marker was higher in
patients exposed to $20 mSv of radiation compared
with those exposed to <20 mSv (3.6% [1.6% to 12.6%]
vs. 1.3% [0.1% to 3.7%]; *p ¼ 0.03). Importantly,
patients receiving radiation doses #7.5 mSv had no
signiﬁcant changes in phosphorylation, suggesting an
absence of detectable DNA damage at very low doses
(p > 0.05) (Figure 2C). Table 1 presents descriptive
and bivariate analysis of patients with or without
DNA damage with clinical and scan parameters. Of the
clinical and demographic parameters evaluated, only
radiation dose was signiﬁcantly associated with the
presence or absence of DNA damage (39.6 mSv [23.6 to
53.8 mSv] vs. 23.2 mSv [8.8 to 31.5 mSv]; *p < 0.0001).
The extent of DNA damage was also correlated with the
amount of radiation exposure (r ¼ 0.48, *p ¼ 0.0001)
(Figure 2D, Online Figure 1). Although iodine dose was
higher in patients who had evidence of DNA damage,
this parameter was not signiﬁcant after adjustment for
multiple comparisons. To assess whether DNA damage
was primarily due to radiation and not contrast effects,
we performed in vitro whole blood irradiation experi-
ments in the absence of contrast. Similar to our in vivo
ﬁndings, biomarkers of DNA damage were consistently
increased at radiation doses above 25 mSv (Online
Figure 2).
EXTENT OF PROGRAMMED CELL DEATH AND ITS
ASSOCIATION WITH DNA DAMAGE AND RADIATION
DOSE. We next measured levels of apoptotic cell
death in a subset of patients before and after under-
going cardiac CTA (n ¼ 25). A total of 60% (15 of 25) of
patients had at least 2-fold increase in apoptosis. The
median increase in apoptosis was 3.1-fold (1.4- to
5.1-fold; p < 0.0001) post-radiation. In absolute
terms, however, the median number of cells under-
going programmed cell death was estimated at 0.7%
(0.5% to 1.28%), which is equivalent to the death of
700 of 100,000 lymphocytes evaluated (Figure 3A).
Median fold apoptosis was highest in patients
exposed to $20 mSv compared to those exposed
to <20 mSv (2.3-fold [1.8- to 3.0-fold] vs. 0.7-fold
[0.7- to 1.0-fold]; *p ¼ 0.03) (Online Figures 3A to 3C).
The degree of apoptosis was more strongly correlated
FIGURE 1 Consort Diagram
82  Patients screened eligible and invited to participate
TCretfadetcellocdoolB27detcellocdoolbenilesaB47
5  Technical issues with cell isolation
8  Excluded
3  Recent x-ray exposure
5  Refused
2  Did not complete CT
1  Technical issue
1  No IV access
72  Cardiac CTAs performed
28  Aorta
23  Coronary 
18  Pre-op valve
3  Left atrium
67  Underwent biomarker assay analysis
41  Both protein and gene expression evaluation
16  Protein expression evaluation only
10  Gene expression evaluation only
Protein expression analysis:
57  Flow cytometry for DNA damage proteins at 0 and 20 min
25  Flow cytometry and immunohistochemistry for apoptosis
at 0, 5, 15, and 30 min; 1, 2, 6, 24, 48 hr; 1wk; and 1 mt
25  Immunohistochemistry for DNA repair kinetics at 0, 5, 15,
and 30 min; 1, 2, 6, 24, 48 hr; 1wk; and 1 mt
Gene expression analysis:
3  Whole genome sequencing at 0 and 24 hr
51  Single cell polymerase chain reaction 
01: 0, 2, 24, 48 hr
01: 0, 2, 24, 48, 1 yr
12: 0, 24 hr
04: 0, 24, 1 yr
03: 0, 24, 48 hr
04: 0, 24, 48, 1 yr
01: 0, 2, 6, 48, 1 wk, 1 mt
17: 0, 2, 6, 24, 48, 1 wk, 1 mt
01: 0, 6, 24, 48, 1 wk
06: 0, 2, 6, 24, 48 hr
01: 0, 2, 6, 24, 48 hr, 1 mt
A consort ﬂow diagram summarizing the participant ﬂow through the study. CT ¼ computed tomography; CTA ¼ computed tomographic angiography; DNA ¼ deoxy-
ribonucleic acid; hr ¼ hour; IV ¼ intravenous; mt ¼ month; wk ¼ week.
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876with the extent of DNA damage (r ¼ 0.78; *p < 0.0001)
(Figure 3B) than the amount of radiation exposure
(r ¼ 0.42; p ¼ 0.03) (Online Figure 3D). The majority
of damaged cells, however, were repaired (Figure 3C).
Although the rate of response of repair and apoptotic
pathways to DNA damage (i.e., disappearance of
excess foci counts per nucleus) varied across in-
dividuals, most patients did not have detectable DNA
damage 2 h after exposure to radiation from cardiac
CTA (Figure 3D, Online Table 3), which is consistent
with a previous study (14).
WHOLE GENOME PROFILING TO EVALUATE CHANGES IN
BIOLOGICAL PATHWAYS AFTER RADIATION EXPOSURE
FROM CARDIAC CTA. Using the transcriptome data of
T lymphocytes from 3 patients (Online Table 4), weperformed gene functional enrichment analyses to
identify biological processes, signaling/metabolic
pathways, and transcription factors that were signif-
icantly associated with radiation exposure. In total,
33 signaling/metabolic pathways, 39 transcription
factors, and 17 biological processes were signiﬁcantly
changed after multiple test correction (q value cutoff
0.1, p values obtained by Fisher exact test) (Figure 4,
Online Figure 4, Online Tables 5 to 8). The active
transcription factors formed a densely connected
regulatory network (Online Figure 4B), with many
transcriptional regulations among them. This sug-
gests that the activity change of some of the signiﬁ-
cant transcription factors may be driven by other
upstream active transcription factors.
TABLE 1 Clinical and Scan Parameters for Patients With and Without DNA Damage
Total
(n ¼ 57)
No DNA Damage
(n ¼ 21)
DNA Damage
(n ¼ 36) p Value
Clinical parameters
Age at enrollment, yrs 67 (56–79) 73 (63–77) 66.5 (54–88) 0.67
Sex 0.33
Male 78.9 (45/57) 71.4 (15/21) 83.3 (30/36)
Female 21.1 (12/57) 28.6 (6/21) 16.7 (6/36)
BMI, kg/m2 26.5 (24.4–29.4) 25.7 (24.2–30.1) 27.1 (24.4–30.2) 0.66
Race
White 80.7 (46/57) 71.4 (15/21) 86.1 (31/36) 0.18
Nonwhite 19.3 (11/57) 28.6 (6/21) 13.9 (5/36)
Current smoking 21.1 (12/57) 14.2 (3/21) 25.0 (9/36) 0.27
History of cancer 22.8 (13/57) 23.8 (5/21) 22.2 (8/36) 0.57
Scan parameters*
Median DLP, mGy$cm 1,511.0 (969.7–2,589.1) 1,105.9 (568.3–1,431.0) 2,137.0 (1,293.0–2,740.9) <0.0001*
Median total effective dose, mSv 36.9 (26.1–61.3) 30.2 (17.0–45.1) 49.2 (32.6–71.3) 0.004*
Median blood radiation dose, mSv 29.8 (18.8–48.8) 23.2 (8.8–31.5) 39.6 (23.6–53.8) <0.0001*
Median iodine content, g 38.6 (33.3–46.9) 35.0 (25.9–37.8) 41.4 (33.3–48.0) 0.01
Values are median (1st to 3rd quartiles) or % (n/N). *Scan parameters reﬂect only the cohort of patients that underwent biomarker testing for DNA damage (n ¼ 57) and do not
reﬂect the entire cohort (n ¼ 67).
BMI ¼ body mass index; DLP ¼ dose length product; DNA ¼ deoxyribonucleic acid.
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877CHANGES IN EXPRESSION OF INDIVIDUAL GENES
ASSOCIATED WITH DNA REPAIR AND APOPTOSIS. To
validate the overall differences in gene expression
after radiation found in the ribonucleic acid se-
quencing analysis, we next measured the expression
levels of a select number of genes involved in the
regulation of apoptosis, cell cycle, and cell repair that
were found to be up-regulated in the whole genome
transcription analysis (Online Tables 1 and 9 to 11).
Radiation exposure from cardiac CTA elicited a sta-
tistically signiﬁcant change in the expression levels of
damage-speciﬁc DNA binding protein 2 (DDB2), x-ray
repair complementing defective repair in Chinese
hamster cells 4 (XRCC4), and BAX over time (*p #
0.01) as shown in Online Figure 5 and Online Table 10.
These genes are known to play important roles in
response to DNA damage. DDB2, for example, facili-
tates DNA binding for nuclear excision repair and
regulates cell fate by promoting cell cycle progression
and programmed cell death (22), whereas XRCC4 has
been found to complex with DNA ligase IV to com-
plete the ﬁnal steps of nonhomologous repair of DNA
double stranded breaks (23). Finally, BAX mediates
p53-dependent apoptosis by inserting into the mito-
chondrial membrane and releasing pro-apoptotic
factors (24). The maximum relative fold change in
gene activation of these genes were signiﬁcantly
increased after cardiac CTA: DDB2: 1.9-fold (1.5- to
3.0-fold); *p < 0.001; XRCC4: 3.0-fold (1.1- to 5.4-
fold); *p ¼ 0.005; BAX: 1.6-fold (0.9- to 2.6-fold);
*p < 0.001 (Figures 5A and 5B). Although DNA repairwas complete within 2 h post-radiation exposure,
peak changes in gene expression occurred 24 h post-
radiation exposure. This ﬁnding is consistent with
previous studies that have reported that transcription
is arrested by DNA damage, but subsequently recovers
after repair is complete to prevent the production of
aberrant transcripts and interference between the
transcription and repair machinery (25–27). Although
gene changes did not vary signiﬁcantly by dose
(Online Figure 5), patients with evidence of DNA
damage had signiﬁcantly higher activation of these
genes compared with those with no DNA damage
(DDB2: 2.55-fold [1.74- to 4.42-fold] vs. 1.26-fold [1.16-
to 1.77-fold]; *p ¼ 0.003; XRCC4: 4.9-fold [2.8- to
6.6-fold] vs. 1.0-fold [0.9- to 1.9-fold]; *p¼ 0.005; BAX:
2.1-fold [1.1- to 2.9-fold] vs. 1.0-fold [0.9- to 1.3-fold],
*p ¼ 0.001) (Figure 5B). In support of these ﬁndings,
gene activation could not be detected in patients re-
ceiving a radiation dose of #7.5 mSv who also had no
evidence of DNA damage as detailed in the previous
text (p > 0.05) (Figure 5C). These ﬁndings suggest that
more extensive DNA damage is associated with greater
transcriptional changes in repair and apoptotic genes.
To assess whether changes were primarily due to ra-
diation and not from contrast effects, experiments
were repeated in vitro in the absence of any contrast.
Similar to our ﬁndings in vivo, increased expression of
several genetic biomarkers associated with cell repair
and death were found after radiation exposure (Online
Figure 6). Importantly, patients who underwent
echocardiography (n ¼ 11) showed no signiﬁcant
FIGURE 2 DNA Damage Detected After Radiation Exposure
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(A) Scatter plot graph of levels of phosphorylated H2A histone family, member X (H2AX), ataxia telangiectasia mutated (ATM), and tumor
protein p53 (p53) at baseline and after exposure to radiation from cardiac CTA (left, n ¼ 57). (B) Quantitative assessment of protein biomarkers
of DNA damage (i.e., levels of phosphorylated H2AX, ATM, and p53) in patients undergoing cardiac CTA (right, n ¼ 57). The horizontal line
within the box marks the median, and the length of the box represents the interquartile range, which is the difference between the 75th and
25th percentiles.Whiskers (error bars) above and below the box indicate the 90th and 10th percentiles. In addition, outliers are indicated by a
dot. *Statistically signiﬁcant at p < 0.01. (C) Quantitative assessment of protein biomarkers of DNA damage in patients receiving very low doses
of radiation (e.g., #7.5 mSv). (D) Scatterplot graph of the correlation analysis between DNA damage estimate and radiation dose (n ¼ 57).
Abbreviations as in Figure 1.
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878change in gene expression post-imaging (data not
shown).
MULTIVARIATE REGRESSION ANALYSIS. Only dose
and iodine content were associated with DNA dam-
age, programmed cell death, and gene activation.
Findings from the bivariate analysis suggest that
iodine content may be a potential confounder,
although the difference between the iodine content
in patients who did and did not have DNA damage
was not signiﬁcant after adjustment for multiple
comparisons (Table 1). Iodine content was found to
correlate with dose (r ¼ 0.67; *p < 0.0001). To deter-
mine the effects of iodine content on the relationship
between dose and DNA damage, we performed the
following set of regressions: 1) DNA damage on dose
alone; 2) DNA damage on iodine content alone; and
3) DNA damage on dose, iodine, and their interaction.Although both DNA damage and iodine content were
signiﬁcant (p < 0.01) when analyzed separately, only
DNA damage remained signiﬁcant when both were
analyzed together. Given the confounding effects
of iodine content, subsequent analyses excluded
this covariate. Results of separate multivariate re-
gressions are summarized in Table 2. Higher radiation
dose was associated with a greater odds of having DNA
damage (odds ratio [OR]: 1.8 [95% conﬁdence interval
(CI): 1.2 to 2.6]; *p ¼ 0.003). Patients with a greater
extent of DNA damage had greater odds of gene acti-
vation (OR: 2.8 [95% CI: 1.2 to 6.2]; *p ¼ 0.002) and
apoptosis (OR: 1.9 [95% CI: 1.2 to 5.1]; *p < 0.0001).
Patients with a greater extent of DNA damage and at
least a 2-fold activation of at least 1 gene had greater
odds of apoptosis (OR: 1.6 [95% CI: 1.2 to 2.7]; *p <
0.0001). Radiation dose was not a statistically
FIGURE 3 Apoptosis Detected After Radiation Exposure
(A) Sample ﬂow cytometry dot plot from a patient after cardiac CTA. To identify apoptotic cells, lymphocytes were ﬁrst isolated using forward and side scatter proﬁles
(left). CD3þ T cells were then identiﬁed from within this subset (middle). Last, apoptotic T cells were detected using Annexin V, an early marker of apoptosis, and
DAPI, an intracellular marker for dead cells, which are either necrotic or at the later stages of apoptosis (right). The estimate of apoptotic cell death includes the sum of
cells that express Annexin only or Annexin-DAPI. This patient had 4.1% of apoptotic cells that express Annexin only and 0.5% of dead cells that express both Annexin and
DAPI. (B) Scatterplot graph of the correlation analysis between the estimates of apoptosis and DNA damage (n ¼ 25). (C) Bar graph displaying the relative percentages of
cells that were repaired or had undergone programmed cell death in individual patients with evidence of cell death by ﬂow cytometry (n ¼ 15). The remainder of the
patients had no cell death and complete repair (n ¼ 10) (not shown in graph). (D) Scatter plot graph of the disappearance of the phosphorylated ataxia telangiectasia
mutated (pATM) over time as damaged cells are repaired or eliminated (n ¼ 25). APC-CD3 ¼ allophycocyanin-cluster differentiation 3; DAPI ¼ 4’,6-diamidino-
2-phenylindole; FSC-A ¼ forward-scatter area; PerCP-Cy5.5 ¼ peridinin chlorophyll protein cyanine 5.5; SSC-A ¼ side-scatter area; other abbreviations as in Figure 1.
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879signiﬁcant predictor of gene activation or apoptosis.
Taken together, it appears that an estimate of radia-
tion dose does not capture the entire spectrum of
biological changes associated with radiation exposure
from cardiac CTA.DISCUSSION
In this study, we demonstrated that patients under-
going cardiac CTA at doses >7.5 mSv had evidence
of DNA damage. This amount of radiation was
FIGURE 4 Strip Charts Showing the Associations of Selected Gene Sets With the Transcriptional Response of Blood Cells to
Cardiac CTA Exposure
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880associated with activation of genes involved in
regulating cell repair and programmed cell death.
Although most damaged cells are repaired, a small
percentage of cells die. These ﬁndings raise the pos-
sibility that radiation exposure at >7.5 mSv from
cardiac CTA may cause DNA damage that can lead to
mutations if damaged cells are not repaired or elimi-
nated properly. Cumulative cell death after repeated
exposures may also be problematic.
Although previous studies have reported cross-
sectional associations between radiation exposure
from medical imaging and DNA damage, these studies
were conducted in either the pediatric population (12)or in small groups of adult patients undergoing CTA
using a single biomarker of damage (13,14,28,29). The
relationship between dosage and DNA damage has
also not been fully explored in adult patients under-
going cardiac CTA (30). In our study, we performed a
comprehensive evaluation of cellular effects of radi-
ation exposure from diagnostic imaging, including
measurements of multiple parameters of DNA dam-
age and apoptosis as well as transcriptional changes
in over 50 patients at serial time points. In a multi-
variate analysis, we found that radiation dose was
associated with DNA damage, although the relation-
ship was only roughly linear (31,32). Dose was not
FIGURE 5 Individual Genes Involved in Apoptosis and Repair Altered After Radiation Exposure
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881predictive of gene activation or programmed cell
death. These results are not surprising, given that we
currently rely on complicated computer simulations
and mathematical models to extrapolate theTABLE 2 Multivariate Regression Model of the Association of DNA D
Multivariate Logistic Regres
DNA Damage
(n ¼ 57)
OR (95% CI) 1.8 (1.2–2.6)* for dose 1.0
2.8 (1.2–
R2 0.2
Model score 13.1‡
p value 0.003
*p < 0.01. †Model that replaces dose with DNA damage given DNA damage captures th
CI ¼ conﬁdence interval; DNA ¼ deoxyribonucleic acid; OR ¼ odds ratio.“absorbed dose” and “biological equivalent dose”
(33), and then use these values to estimate biological
risk (i.e., cellular injury and cancer risk) (34). Our
ﬁndings suggest that measurement of the degree ofamage, Gene Activation, and Apoptosis With Dose
sion Exact Logistic Regression
Gene Activation
(n ¼ 51)
Apoptosis
(n ¼ 25)
(0.99–1.1) for dose
6.2)* for DNA damage†
1.1 (1.0–1.2) for dose
1.9 (1.2–5.1)* for DNA damage†
1.6 (1.2–2.7)* for gene activation
0.16 —
8.2‡ 16.4
0.002 <0.0001
e effects of dose. ‡Chi-square for likelihood ratio test.
Nguyen et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 8 , 2 0 1 5
Cardiac CTA, Radiation Effects, and Biomarkers A U G U S T 2 0 1 5 : 8 7 3 – 8 4
882DNA damage is more predictive of both gene activa-
tion and apoptosis than estimated radiation dose and
may be a better marker of biological risks.
Importantly, in this study, we purposely recruited
patients who had a wide range of radiation dose to
determine its effects on cellular damage. Patients
with radiation exposure >20 mSv either underwent a
CTA performed in a traditional scanner equipped with
older technology (Discovery 750HD, GE, Milwaukee,
Wisconsin) and retrospective gating or underwent an
evaluation of their entire aorta (e.g. patients with a
history of dissection or pre-transcatheter aortic valve
replacement) using a state-of-the-art dual source
scanner (Sensation Dual Source, Siemens Medical
Solutions, Forchheim, Germany) and prospective
gating. In patients undergoing coronary angiography
using a dual source scanner where radiation doses
were #7.5 mSv, no damage was observed, further
supporting a dose-response relationship. Overall,
these data are consistent with our hypothesis that
higher radiation dose leads to more DNA damage.
In addition to evaluating the relationship between
dose and DNA damage, we provide a comprehensive
analysis of how cells respond to damage, which has
not been evaluated in prior studies. Our study found
that exposure to radiation from CTA, like exposure to
therapeutic doses of radiation (17,18,35,36), activates
biological pathways and genes and increases the ac-
tivity of transcription factors involved in the regula-
tion of cell repair, cell cycle progression, and
apoptosis, which are critical in preventing the
development of mutations, a ﬁnding that has not yet
been previously reported. Although cells with DNA
damage are mostly repaired, a small number of cells
die after radiation exposure from CTA. These ﬁndings
are consistent with known biological responses to
DNA damage (11). Cells with insigniﬁcant damage
can be repaired, whereas those cells with extensive
damage undergo programmed cell death to minimize
the risk of mutation. We found a complete resolution
of DNA damage occurred within 2 h of exposure in the
majority of patients, which is also consistent with
prior studies (14). In a few patients, however, residual
DNA damage persisted and continued activation of
cellular response pathways was detectable up to 1
month post-exposure, which has been reported after
exposure to radiation doses as low as 1 mGy in vitro.
This supports a possible lack of efﬁcient cellular
activation of repair mechanisms at dosing levels
typically used in medical imaging (21). If residual cells
are not eventually repaired or eliminated, they can
potentially retain mutations. The number of cells
with residual DNA damage after radiation exposure
from CTA, however, is small (<1%). The number oflymphocytes that died after imaging is also small
(<1%). Nevertheless, cumulative cell death from
repeated radiation exposure can be potentially
harmful, especially in elderly patients who may have
a limited pool of naïve T cells that respond to novel
pathogens (37). Further study is needed to evaluate
whether the subpopulation of naïve T cells is affected
by radiation exposure from CTA.
STUDY LIMITATIONS. A potential limitation of the
study is that we did not directly measure DNA dam-
age. However, a direct measure of small changes in
DNA damage is not possible with current techniques
(38). This study also did not measure the risk of
cancer from radiation exposure from cardiac CTA
because only cells that evade cellular repair and
programmed cell death survive and produce cancer
long-term. Because identifying these cells is not yet
feasible, interpretation of these ﬁndings should be
limited to the cellular effects of radiation from CTA in
the short-term. Although this study was not designed
to assess cancer risk, it does provide valuable insight
into the biological response to radiation from medical
imaging.
CONCLUSIONS
Patients undergoing cardiac CTA have evidence of
DNA damage in T lymphocytes, which is associated
with death of a small fraction of cells and activation
of biological pathways, transcription factors, and
genes involved in cell repair and apoptosis. Although
cardiac CTA is a valuable clinical tool in the man-
agement of patients with cardiovascular disease,
awareness among physicians and patients that DNA
damage and apoptosis can occur even after diagnostic
imaging may encourage greater adherence to dose
reduction strategies. Further research is needed to
develop novel agents to protect patients from the
potential adverse effects of radiation exposure from
cardiac CTA.
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PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Cardiovascular
imaging remains the cornerstone for the management of
complex cardiovascular disease. Due to our rapidly growing
reliance on imaging for diagnosis and monitoring, many pa-
tients now receive more radiation from medical imaging than
ever before, a trend that will likely continue to accelerate. This
raises growing concerns about the potential risk from exposure
to low-dose radiation from medical imaging. For instance,
lymphocyte DNA damage has been detected in patients who
undergo computed tomographic imaging, with the amount of
damage seemingly proportional to dosage. Notably in this
study, DNA damage was not detected in patients who received
doses lower than or equal to 7.5 mSv, which is equivalent to
50 chest x-rays or 1 cardiac CTA using state-of-the-art
technology. These results support the need to adhere to dose
reduction strategies and minimize radiation exposure in medi-
cal imaging, although more extensive studies need to be con-
ducted to reﬁne the thresholds of harmful exposure to other
tissues.
TRANSLATIONAL OUTLOOK: Further studies are war-
ranted to identify certain patients who may be at a greater risk
of DNA damage from low-dose radiation as well as beneﬁcial
compounds that may protect patients from the potential
adverse effects of imaging.
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